Stage IV Squamous Cell Carcinoma of the Nasopharynx Terminated Phase 2 Trials for Fosaprepitant (DB06717)

IndicationStatusPhase
DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00895245Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapySupportive Care